Page last updated: 2024-11-06

phenylsulfate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Phenylsulfate is a sulfate ester of phenol. It is a colorless, odorless solid that is soluble in water. Phenylsulfate is a naturally occurring compound found in the urine of mammals, including humans. It is also a byproduct of the metabolism of various compounds, including phenol and its derivatives.

Phenylsulfate is formed in the liver by the action of sulfotransferases. These enzymes catalyze the transfer of a sulfate group from 3'-phosphoadenosine-5'-phosphosulfate (PAPS) to phenol. Phenylsulfate is then excreted in the urine.

The biological effects of phenylsulfate are not well understood. However, it is known that phenylsulfate can inhibit the activity of certain enzymes, such as tyrosinase. Tyrosinase is an enzyme that is involved in the production of melanin, the pigment that gives skin its color. Inhibition of tyrosinase by phenylsulfate could potentially lead to depigmentation of the skin.

Phenylsulfate is also studied in the context of its role in detoxification. Phenol is a toxic compound that can be harmful to the body. Phenylsulfate is one of the main detoxification pathways for phenol. By converting phenol to phenylsulfate, the body is able to excrete it in the urine and prevent its accumulation in the body.

In addition to its role in detoxification, phenylsulfate may also play a role in the regulation of other biological processes. For example, it has been shown to inhibit the growth of certain types of cancer cells. More research is needed to fully understand the biological effects of phenylsulfate.
'

phenylsulfate: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

phenyl hydrogen sulfate : An aryl sulfate that is phenol bearing an O-sulfo substituent. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID74426
CHEBI ID27905
SCHEMBL ID138895
MeSH IDM0084309

Synonyms (25)

Synonym
phenyl wasserstoff sulfat
CHEBI:27905
phenyl hydrogen sulfate
C02180
937-34-8
C00850
phenol sulfate
phenylsulfate
aryl sulfate
sulfuric acid, monophenyl ester
unii-2l4rkm5351
2l4rkm5351 ,
SCHEMBL138895
DTXSID50239545
phenyl hydrogen sulphate
phenylsulphate
phenol sulphate
aryl sulphate
DB14667
Q27103399
FT-0778050
phenyloxidanesulfonic acid
CS-0883163
HY-128442
EN300-1716833

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Saturation of benzene metabolism could limit the production of toxic species."( Hematotoxicity and concentration-dependent conjugation of phenol in mice following inhalation exposure to benzene.
Nerland, DE; Wells, MS, 1991
)
0.28

Dosage Studied

ExcerptRelevanceReference
" The immersion dosing method employed for the experiment is discussed with relation to the natural habitat of the fish."( The biotransformation of [14C]phenol in some freshwater fish.
Layiwola, PJ; Linnecar, DF, 1981
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
human xenobiotic metaboliteAny human metabolite produced by metabolism of a xenobiotic compound in humans.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
aryl sulfate
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (6)

PathwayProteinsCompounds
Metabolism14961108
Biological oxidations150276
Phase II - Conjugation of compounds73122
Cytosolic sulfonation of small molecules1747
Sulfate/Sulfite Metabolism620
Sulfite Oxidase Deficiency620

Research

Studies (25)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (36.00)18.7374
1990's2 (8.00)18.2507
2000's2 (8.00)29.6817
2010's9 (36.00)24.3611
2020's3 (12.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.91

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.91 (24.57)
Research Supply Index3.37 (2.92)
Research Growth Index5.13 (4.65)
Search Engine Demand Index44.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.91)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (3.70%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other26 (96.30%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]